These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2180032)

  • 1. [Helixor--mistletoe preparation for cancer therapy. Documentation No. 19].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(10):291-5. PubMed ID: 2180032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iscucin--mistletoe preparations for the pre- and postoperative treatment of malignancies. Documentation No. 21].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Apr; 79(14):427-9. PubMed ID: 2343229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
    Kelter G; Schierholz JM; Fischer IU; Fiebig HH
    Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
    Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
    [No Abstract]   [Full Text] [Related]  

  • 6. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
    Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
    Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of mistletoe therapy in carcinoma patients].
    Rostock M; Unger C
    Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
    [No Abstract]   [Full Text] [Related]  

  • 10. Apparent response of small cell lung cancer to an extract of mistletoe and homoeopathic treatment.
    Bradley GW; Clover A
    Thorax; 1989 Dec; 44(12):1047-8. PubMed ID: 2559483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anthroposophy. Mistletoe preparations: a cancer inhibiting wonder drug?].
    Arm F
    Krankenpfl Soins Infirm; 1989 May; 82(5):18-21. PubMed ID: 2747189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possibilities and limits of mistletoe therapy in cancer patients].
    Hoffmann J
    Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mistletoe therapy in cancer treatment: pros and cons].
    Wiebelitz KR; Beer AM; Heinrich B
    MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
    [No Abstract]   [Full Text] [Related]  

  • 15. Mistletoe in immunology and the clinic (short review).
    Stein GM; Schietzel M; Büssing A
    Anticancer Res; 1998; 18(5A):3247-9. PubMed ID: 9858890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mistletoe therapy. An alternative cancer treatment].
    Ernst E
    MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview on anticancer activities of the Viscum album extract Isorel.
    Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
    Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
    Wrotek S; Skawiński R; Kozak W
    Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mistletoe in the treatment of cancer].
    Bruseth S; Enge A
    Tidsskr Nor Laegeforen; 1993 Mar; 113(9):1058-60. PubMed ID: 8493669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.